Read our Pleio Ponderings, case studies, news, white papers, blog posts, and webinars to gain insight on the industry.
Pleio’s Chief Pharmacy Officer Mark Gregory, RPh discusses how oral GLP-1 medication will impact the patient medication journey, highlighting how easier access may improve initiation but not necessarily adherence. He explores how fragmented support, knowledge gaps, and emotional barriers can undermine persistence, and why sustained outcomes will depend on coordinated guidance beyond the prescription.
